Neuroone Medical Technologies Quick Ratio (NMTC) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Neuroone Medical Technologies Corp  (NASDAQ: NMTC)

Neuroone Medical Technologies's Quick Ratio

NMTC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 1.66 below Neuroone Medical Technologies's average Quick Ratio.

Within Medical Equipment & Supplies industry 89 other companies have achieved higher Quick Ratio than Neuroone Medical Technologies in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 460 to 1397.

Explain Quick Ratio?
How much Cash & cash equivalents NMTC´s has?
What are NMTC´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NMTC Quick Ratio (Mar 31 2026)
Q2		 (Dec 31 2025)
Q1		 (Sep 30 2025)
Q4		 (Jun 30 2025)
Q3		 (Mar 31 2025)
Q2
Y / Y Current Liabilities Change -4.19 % -7.78 % 36.2 % -7.45 % -1.63 %
Y / Y Cash & cash equivalent Change 112.38 % 235.22 % 305.58 % 230.22 % -75.19 %
Quick Ratio MRQ 1.66 2.85 2.85 5.64 0.75
NMTC's Total Ranking # 1397 # 460 # 826 # 442 # 1274
Seq. Current Liabilities Change -26.64 % 0 % 61.53 % -19.14 % -29.39 %
Seq. Cash & cash equivalent Change -57.32 % 0 % -18.28 % 508.95 % -32.64 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 90
Healthcare Sector # 539
Overall Market # 1397


Quick Ratio Statistics
High Average Low
15.88 3.04 0
(Mar 31 2022)   (Sep 30 2015)




Financial Statements
Neuroone Medical Technologies's Current Liabilities $ 2 Millions Visit NMTC's Balance sheet
Neuroone Medical Technologies's Cash & cash equivalent $ 3 Millions Visit NMTC's Balance sheet
Source of NMTC's Sales Visit NMTC's Sales by Geography


Cumulative Neuroone Medical Technologies's Quick Ratio

NMTC's Quick Ratio for the trailling 12 Months

NMTC Quick Ratio

 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth 3.06 % 3.64 % 17.2 % 7.33 % 8.84 %
Y / Y Cash & cash equivalent TTM Growth 226.99 % 98.47 % 21.71 % -19.94 % -59.98 %
Quick Ratio TTM 3.11 2.89 2.24 1.75 0.98
Total Ranking TTM # 3715 # 1919 # 3103 # 3126 # 2575
Seq. Current Liabilities TTM Growth -0.95 % -2.43 % 8.3 % -1.53 % -0.39 %
Seq. Cash & cash equivalent TTM Growth 6.59 % 25.77 % 38.26 % 76.42 % -35.3 %

Quick ratio ranking by company, industry and sector >> Back to NMTC Financial Strength Comparisons >> Go to Compare NMTC Quick Ratio to its Competitors

On the trailing twelve months basis NMTC Cash & cash equivalent more than doubled by 112.38 % in Q2 2026 year on year, while Current Liabilities plummeted to $2 millions, this led to increase in in Neuroone Medical Technologies's Quick Ratio to 3.11, Quick Ratio remained below NMTC average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 195 other companies have achieved higher Quick Ratio than Neuroone Medical Technologies. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2025 from 1919 to 3715.

Explain Quick Ratio?
How much Cash & cash equivalents NMTC´s has?
What are NMTC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 196
Healthcare Sector # 872
Within the Market # 3715


trailing twelve months Quick Ratio Statistics
High Average Low
11.92 4.61 0.05
(Jun 30 2022)   (Jul 31 2015)




Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Medical Equipment & Supplies Industry Quick RatioMar 31 2026 MRQ Cash & cash equivalentMar 31 2026 MRQ Current Liabilities
Biolife Solutions Inc   4.44 $ 80.996  Millions$ 18.253  Millions
Soleno Therapeutics Inc  4.40 $ 255.599  Millions$ 58.049  Millions
Inspiremd Inc   4.40 $ 41.570  Millions$ 9.443  Millions
Axogen inc   4.25 $ 101.601  Millions$ 23.898  Millions
Outset Medical Inc   4.17 $ 156.706  Millions$ 37.607  Millions
Innovative Eyewear Inc   4.14 $ 4.378  Millions$ 1.059  Millions
Autonomix Medical Inc   4.11 $ 7.004  Millions$ 1.705  Millions
Fractyl Health Inc   4.10 $ 63.168  Millions$ 15.408  Millions
Hyperfine Inc   4.02 $ 40.778  Millions$ 10.154  Millions
Orasure Technologies Inc  4.01 $ 176.964  Millions$ 44.084  Millions
Kestra Medical Technologies Ltd   3.90 $ 196.434  Millions$ 50.372  Millions
Procept Biorobotics Corporation  3.86 $ 245.641  Millions$ 63.636  Millions
Clearpoint Neuro Inc   3.75 $ 35.593  Millions$ 9.480  Millions
Mimedx Group Inc   3.59 $ 159.773  Millions$ 44.550  Millions
Aethlon Medical Inc   3.47 $ 5.026  Millions$ 1.447  Millions
Novocure Limited  3.40 $ 432.004  Millions$ 127.239  Millions
Nexalin Technology Inc   3.35 $ 2.708  Millions$ 0.808  Millions
Capsovision Inc   3.34 $ 17.933  Millions$ 5.363  Millions
Neuropace Inc   3.34 $ 53.981  Millions$ 16.168  Millions
Apyx Medical Corp  3.30 $ 31.137  Millions$ 9.447  Millions
Pulmonx Corporation  3.26 $ 61.572  Millions$ 18.906  Millions
Anika Therapeutics Inc   3.19 $ 66.788  Millions$ 20.966  Millions
Inspire Medical Systems inc   3.17 $ 283.834  Millions$ 89.418  Millions
Sensus Healthcare Inc   3.13 $ 18.327  Millions$ 5.859  Millions
Glaukos Corp  3.09 $ 276.685  Millions$ 89.415  Millions
Strata Critical Medical Inc   2.96 $ 59.053  Millions$ 19.955  Millions
Vivani Medical Inc   2.91 $ 19.749  Millions$ 6.775  Millions
Penumbra Inc  2.91 $ 615.660  Millions$ 211.731  Millions
Tandem Diabetes Care Inc   2.86 $ 570.256  Millions$ 199.075  Millions
Valion Bio Inc   2.76 $ 7.215  Millions$ 2.615  Millions

Date modified: 2026-09-18T10:53:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.